Cargando…
Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
PURPOSE: Tumor-associated macrophages (TAMs) are activated macrophages associated with tumor progression in various cancers. TAMs can polarize M1 or M2 type. M1 has a pro-inflammatory function and kills pathogens. Conversely, M2 shows immunosuppressive action and promotes tumor growth. There are var...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438840/ https://www.ncbi.nlm.nih.gov/pubmed/30941232 http://dx.doi.org/10.4048/jbc.2019.22.e5 |
_version_ | 1783407155407224832 |
---|---|
author | Jeong, Hasong Hwang, Ilseon Kang, Sun Hee Shin, Hyeong Chan Kwon, Sun Young |
author_facet | Jeong, Hasong Hwang, Ilseon Kang, Sun Hee Shin, Hyeong Chan Kwon, Sun Young |
author_sort | Jeong, Hasong |
collection | PubMed |
description | PURPOSE: Tumor-associated macrophages (TAMs) are activated macrophages associated with tumor progression in various cancers. TAMs can polarize M1 or M2 type. M1 has a pro-inflammatory function and kills pathogens. Conversely, M2 shows immunosuppressive action and promotes tumor growth. There are various markers of TAMs. CD11c is considered as a specific marker of M1. CD163 is an optimal marker for M2. CD68 is known as a pan-macrophage marker. We evaluated the relationship between the clinicopathological parameters and immunohistochemical expressions of CD11c, CD163, and CD68 in invasive breast cancer (IBC), and the prognostic value of macrophage localization within the tumor stroma (TS) and tumor nest (TN). METHODS: Immunohistochemistry of CD68, CD11c, and CD163 was analyzed on tissue microarrays of 367 IBCs. The number of CD68+, CD11c+, or CD163+ macrophages in TN vs. TS was counted by 2 pathologists. The correlations between the degree of macrophage (CD68+, CD11c+, or CD163+) infiltration and the clinicopathological parameters were analyzed. We also assessed the impact of macrophages (CD68+, CD11c+, or CD163+) on disease free survival (DFS) and overall survival (OS). RESULTS: High numbers of macrophages (CD68+, CD11c+, or CD163+) were associated with higher histologic grade, higher Ki-67 proliferating index, estrogen receptor negativity, and progesterone receptor negativity. High numbers of macrophages (CD11c+ or CD163+) in TS were associated with a larger tumor size. Furthermore, CD163+ macrophages in TN were an independent prognostic marker of reduced OS and DFS. Conversely, CD11c+ macrophages in TS were an independent prognostic marker for higher OS and DFS. CONCLUSION: TAMs, including M2 type, are associated with tumor progression in IBC. They can also act as a significant unfavorable or favorable prognostic factor. In addition to simply analyzing the degree of TAM infiltration, it is also important to analyze the location of TAMs. |
format | Online Article Text |
id | pubmed-6438840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Korean Breast Cancer Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-64388402019-04-02 Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer Jeong, Hasong Hwang, Ilseon Kang, Sun Hee Shin, Hyeong Chan Kwon, Sun Young J Breast Cancer Original Article PURPOSE: Tumor-associated macrophages (TAMs) are activated macrophages associated with tumor progression in various cancers. TAMs can polarize M1 or M2 type. M1 has a pro-inflammatory function and kills pathogens. Conversely, M2 shows immunosuppressive action and promotes tumor growth. There are various markers of TAMs. CD11c is considered as a specific marker of M1. CD163 is an optimal marker for M2. CD68 is known as a pan-macrophage marker. We evaluated the relationship between the clinicopathological parameters and immunohistochemical expressions of CD11c, CD163, and CD68 in invasive breast cancer (IBC), and the prognostic value of macrophage localization within the tumor stroma (TS) and tumor nest (TN). METHODS: Immunohistochemistry of CD68, CD11c, and CD163 was analyzed on tissue microarrays of 367 IBCs. The number of CD68+, CD11c+, or CD163+ macrophages in TN vs. TS was counted by 2 pathologists. The correlations between the degree of macrophage (CD68+, CD11c+, or CD163+) infiltration and the clinicopathological parameters were analyzed. We also assessed the impact of macrophages (CD68+, CD11c+, or CD163+) on disease free survival (DFS) and overall survival (OS). RESULTS: High numbers of macrophages (CD68+, CD11c+, or CD163+) were associated with higher histologic grade, higher Ki-67 proliferating index, estrogen receptor negativity, and progesterone receptor negativity. High numbers of macrophages (CD11c+ or CD163+) in TS were associated with a larger tumor size. Furthermore, CD163+ macrophages in TN were an independent prognostic marker of reduced OS and DFS. Conversely, CD11c+ macrophages in TS were an independent prognostic marker for higher OS and DFS. CONCLUSION: TAMs, including M2 type, are associated with tumor progression in IBC. They can also act as a significant unfavorable or favorable prognostic factor. In addition to simply analyzing the degree of TAM infiltration, it is also important to analyze the location of TAMs. Korean Breast Cancer Society 2019-01-02 /pmc/articles/PMC6438840/ /pubmed/30941232 http://dx.doi.org/10.4048/jbc.2019.22.e5 Text en © 2019 Korean Breast Cancer Society https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Jeong, Hasong Hwang, Ilseon Kang, Sun Hee Shin, Hyeong Chan Kwon, Sun Young Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer |
title | Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer |
title_full | Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer |
title_fullStr | Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer |
title_full_unstemmed | Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer |
title_short | Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer |
title_sort | tumor-associated macrophages as potential prognostic biomarkers of invasive breast cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438840/ https://www.ncbi.nlm.nih.gov/pubmed/30941232 http://dx.doi.org/10.4048/jbc.2019.22.e5 |
work_keys_str_mv | AT jeonghasong tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer AT hwangilseon tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer AT kangsunhee tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer AT shinhyeongchan tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer AT kwonsunyoung tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer |